TBMis always looking for great medical ideas that improve life and health.
Our deal flow comes primarily from collaborations with leading US research hospitals and universities, which provide us with exposure to the forefront of clinical innovation.
Additionally, TBM has established a comprehensive group of clinical subject matter experts and key opinion leaders to assess clinical innovations for their product-market fit.
TBM’s fresh approach to R&D and technology licensing continues to establish robust, innovative product lines and solid technological reserves channels. Any challenges along the way are overcome by our strong relationships with advanced-capacity Chinese suppliers.
Working as a team, we develop innovative medical devices that are supported with a strong product-market fit and that are secured by worldwide intellectual property protection, both of which are need to enhance the worldwide commercialization opportunity. TBM’s current projects include twoinnovative technologies in the areas of cardiology and dental care.
Advancing medical technology from ideas into reality.
Vision
By 2025, to be leaders in medical technology commercialization - courageous to explore, vital in life, and efficient in our methods.
Our Team
Brad YangManaging Partner
◆19-year career, including 10+ years in the capital markets and cross-border investments. Successful positions at Morgan Stanley and Georgetown Investment Office
◆MBA from McDonough School of Business at Georgetown University (Beta Gamma Sigma) and Chartered Financial Analyst charterholder
Elliot ReedPartner
◆Actively involved in the commercialization of early-stage bioscience technologies. Senior level executive positions for the past 12 years
◆JD, specializing in business formation and intellectual property, and MBA, concentrating in Bioscience Entrepreneurship and Finance, from Case Western Reserve University
Lilian LiCOO
◆10+ years experience of finance, cross-border investment and tax planning. Previous successful experience at KPMG and L'Oréal
◆BS in Economics from Fudan University (top 3 university in China) and Certified Public Accountant (CICPA)
Charles ZhangR&D Director
◆Eight years experience in a public medical device company as R&D director
◆Master of Science in Polymer Chemistry and Physics from University of Chinese Academy of Sciences and BS in Polymer Materials & Engineering from Zhejiang University (top 5 university in China)
Judith ZhengMedical Affairs
◆Strong academic background in biotech and five years’ experiences in venture capital investment
◆BS in Biological Science and BE in Entrepreneurship and Management from Zhejiang University (top 5 university in China)
Authur ZhangR&D Manager
◆Previous experience at Siemens Corporation Technology and Shanghai YuHua Medical Device Company.
◆Master of Science in Mechanical Engineering from UIUC. Bachelor of Science in Mechanical Engineering from Shanghai Jiao Tong University.